Fund Universe

Ally Bridge Group (NY) LLC

CIK 0001822947 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.014
AUM ($M)
78
Positions
23
Turnover
0.52
Top-10 wt
65%
Herfindahl
0.065
History (qtrs)
6
Excess Return
not eligible

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 31 positions · portfolio value $78M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
NERV funds › MINERVA NEUROSCIENCES INC ADD 15.6% +5.7% 12.1 2,175,802 +520,302 2
PMN funds › PROMIS NEUROSCIENCES INC ADD 10.5% +5.3% 8.2 620,319 +206,100 2
TRAX funds › FIRST TRACKS BIOTHERAPEUTICS NEW 7.4% +7.4% 5.7 284,287 +284,287 1
AXSM funds › AXSOME THERAPEUTICS INC NEW 5.2% +5.2% 4.0 16,493 +16,493 1
ASMB funds › ASSEMBLY BIOSCIENCES INC NEW 5.0% +5.0% 3.8 140,000 +140,000 1
WHWK funds › WHITEHAWK THERAPEUTICS INC HOLD Common Stock 4.8% +2.0% 3.7 817,939 +0 2
EWTX funds › EDGEWISE THERAPEUTICS INC TRIM 4.4% -0.7% 3.4 83,300 -77,700 2
CLYM funds › CLIMB BIO INC NEW 4.2% +4.2% 3.2 249,172 +249,172 1
KURA funds › KURA ONCOLOGY INC NEW 4.1% +4.1% 3.2 290,000 +290,000 1
CTMX funds › CYTOMX THERAPEUTICS INC. TRIM 3.7% -0.5% 2.9 775,000 -125,000 2
AVTX funds › AVALO THERAPEUTICS INC NEW 3.6% +3.6% 2.8 150,000 +150,000 1
PALI funds › PALISADE BIO INC NEW 3.3% +3.3% 2.6 1,229,000 +1,229,000 1
SLDB funds › SOLID BIOSCIENCES INC TRIM 3.3% -2.2% 2.6 255,959 -511,015 2
ANTX funds › AN2 THERAPEUTICS INC HOLD 3.3% +1.5% 2.5 526,315 +0 2
URGN funds › UROGEN PHARMA LTD TRIM 3.3% -0.3% 2.5 69,183 -132,941 2
CATX funds › PERSPECTIVE THERAPEUTICS INC TRIM 3.3% -0.6% 2.5 743,958 -182,599 2
IDYA funds › IDEAYA BIOSCIENCES INC NEW 3.2% +3.2% 2.5 67,500 +67,500 1
IVA funds › INVENTIVA SA TRIM 3.1% -1.0% 2.4 634,800 -110,500 2
ALMS funds › ALUMIS INC TRIM 2.8% -0.9% 2.2 76,459 -90,500 2
OVID funds › OVID THERAPEUTICS INC TRIM 2.2% -4.1% 1.7 624,561 -2,193,898 2
EPRX funds › EUPRAXIA PHARMACEUTICALS INC TRIM 2.1% -2.6% 1.7 252,175 -408,200 2
IBIO funds › IBIO INC NEW 0.9% +0.9% 0.7 390,147 +390,147 1
TRAW funds › TRAWS PHARMA INC NEW 0.9% +0.9% 0.7 786,236 +786,236 1
IKT funds › INHIBIKASE THERAPEUTICS INC EXIT 0.0% -2.2% 0.0 0 -1,325,000 0
RLMD funds › RELMADA THERAPEUTICS INC EXIT 0.0% -1.5% 0.0 0 -210,525 0
CUSIP:834203309 funds › SOLENO THERAPEUTICS INC EXIT 0.0% -6.7% 0.0 0 -200,000 0
CAPR funds › CAPRICOR THERAPEUTICS INC EXIT 0.0% -3.4% 0.0 0 -113,899 0
CMPS funds › COMPASS PATHWAYS PLC EXIT 0.0% -5.7% 0.0 0 -1,045,000 0
TARS funds › TARSUS PHARMACEUTICALS INC EXIT 0.0% -5.6% 0.0 0 -80,859 0
PRAX funds › PRAXIS PRECISION MEDICINES I EXIT 0.0% -10.5% 0.0 0 -32,810 0
ABVX funds › ABIVAX SA EXIT 0.0% -3.7% 0.0 0 -33,712 0

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 78 23 0.52 65% 0.065 0.014 in
2026Q1 101 21 0.43 65% 0.058 0.041 entered
2025Q4 63 13 0.65 90% 0.097 0.000 out
2025Q3 119 18 0.63 79% 0.085 0.000 left
2025Q2 120 24 0.53 65% 0.064 0.019 entered
2025Q1 111 28 0.00 65% 0.054 0.000 out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status